Twenty-four-hour effectiveness of BMS 180048 in the acute treatment of migraine headaches

Headache

Volumn 37, Issue 4, 1997, Pages 245-248

  Ryan R E , Jr ^a   Elkind, A ^a   Goldstein, J ^a  

^a Ryan Headache Center   (United States)

Author keywords

5 HT1 agonist; abortive therapy; BMS 180048; migraine headache

Indexed keywords

AVITRIPTAN;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DOSE TIME EFFECT RELATION; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; HOLTER MONITORING; HUMAN; MAJOR CLINICAL STUDY; MIGRAINE; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RELAPSE;

ACUTE DISEASE; DOUBLE-BLIND METHOD; HUMANS; INDOLES; MIGRAINE DISORDERS; SALVAGE THERAPY; SEROTONIN AGONISTS; SULFONAMIDES; TIME FACTORS; TRYPTAMINES;

EID: 0030962203     PISSN: 00178748     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1526-4610.1997.3704245.x     Document Type: Article

References (0)